| CATALYST PHARMACEUTICALS, INC. | CPRX | Gary IngenitoChiefDERIV | May 14 | MOption exercise | 44,000 | $0.00 | —? | 546,282derivatives |
| CATALYST PHARMACEUTICALS, INC. | CPRX | Gary IngenitoChiefDERIV | May 13 | MOption exercise | 200,000 | $0.00 | —? | 590,282derivatives |
| CATALYST PHARMACEUTICALS, INC. | CPRX | Gary IngenitoChief | May 14 | S | 44,000 | $23.63 | $1.0M | 68,873 |
| CATALYST PHARMACEUTICALS, INC. | CPRX | Gary IngenitoChief | May 14 | MOption exercise | 44,000 | $4.64 | $204K | 112,873 |
| CATALYST PHARMACEUTICALS, INC. | CPRX | Gary IngenitoChief | May 13 | S | 200,000 | $23.68 | $4.7M | 68,873 |
| CATALYST PHARMACEUTICALS, INC. | CPRX | Gary IngenitoChief | May 13 | MOption exercise | 200,000 | $3.42 | $684K | 268,873 |
| CATALYST PHARMACEUTICALS, INC. | CPRX | Gary IngenitoChiefDERIV | Mar 6 | MOption exercise | 180,096 | $0.00 | —? | 790,282derivatives |
| CATALYST PHARMACEUTICALS, INC. | CPRX | Gary IngenitoChiefDERIV | Mar 5 | MOption exercise | 44,904 | $0.00 | —? | 970,378derivatives |
| CATALYST PHARMACEUTICALS, INC. | CPRX | Gary IngenitoChief | Mar 6 | S | 180,096 | $21.67 | $3.9M | 68,873 |
| CATALYST PHARMACEUTICALS, INC. | CPRX | Gary IngenitoChief | Mar 6 | MOption exercise | 180,096 | $2.24 | $403K | 248,969 |
| CATALYST PHARMACEUTICALS, INC. | CPRX | Gary IngenitoChief | Mar 5 | S | 44,904 | $22.09 | $992K | 68,873 |
| CATALYST PHARMACEUTICALS, INC. | CPRX | Gary IngenitoChief | Mar 5 | MOption exercise | 44,904 | $2.24 | $101K | 113,777 |
| CATALYST PHARMACEUTICALS, INC. | CPRX | Gary IngenitoChiefDERIV | Feb 14 | MOption exercise | 10,000 | $0.00 | —? | 1,015,282derivatives |
| CATALYST PHARMACEUTICALS, INC. | CPRX | Gary IngenitoChief | Feb 14 | FTax withholding | 2,435 | — | — | 68,873 |
| CATALYST PHARMACEUTICALS, INC. | CPRX | Gary IngenitoChief | Feb 14 | MOption exercise | 10,000 | — | — | 71,308 |